Yellow Fever virus Archives - The Native Antigen Company

Jul 10, 2019Dengue Virus, Flaviviruses, New products, Research, Tick-Borne Disease, Yellow Fever virus, Zika

The world’s most extensive range of NS1-specific antibodies for flavivirus research

The Native Antigen Company first gained prominence in 2016, when it developed highly pure Zika virus NS1 protein during the 2015/2016 epidemic. Since then, the company has developed an extensive range of highly specific antigens, antibodies and immunoassays for...

Jun 12, 2019Dengue Virus, New products, Research, Yellow Fever virus, Zika

Viral Lysates for Diagnostic Research

We’ve recently expanded our range of native viral cell lysates to complement our highly pure recombinant antigens. Here, we explain how our lysates are made and their uses in infectious disease R&D. What are viral lysates? Put simply, viral lysates are...

Apr 25, 2019CMV, Ebola virus, Immunofluorescence, Research, Yellow Fever virus

New Immunofluorescence Data for our CMV, Yellow Fever and Ebola Antibodies

In September 2018 The Native Antigen Company and Virology Research Services (VRS) were awarded the Medical Research Council (Proximity to Discovery Award for Knowledge Exchange) to test a large panel of our viral antibodies in immunofluorescence applications. This...

Dec 10, 2018Disease insight, Yellow Fever virus

Challenges to Effective Yellow Fever Diagnostics

Yellow fever is a haemorrhagic viral disease, transmitted by infected mosquitos in Africa and South America. While an effective vaccine is available, inadequate vaccination of endemic areas has made diagnostics a necessity to controlling ongoing outbreaks. However,...

The world’s most extensive range of NS1-specific antibodies for flavivirus research

Viral Lysates for Diagnostic Research

New Immunofluorescence Data for our CMV, Yellow Fever and Ebola Antibodies

Challenges to Effective Yellow Fever Diagnostics

Recent Posts

Archives

Categories